Details How Deep Track’s Independent Nominees Will Prioritize Shareholder-Aligned Capital Allocation Decisions and Help Set Value-Maximizing Strategy in the Boardroom Visit www.RefocusDVAX.com to ...
Believes Company’s Unwillingness to Reach Mutually Acceptable Resolution – And Opposition to Giving Shareholders a Voice in the Boardroom – Underscores the Board’s Entrenchment and the Clear Need for ...
Cites Evidence That the Company is Not Living Up to Its Potential, As Demonstrated By 26% Year-To-Date Share Price Decline, Underperformance Versus Benchmarks, Precipitous 11% Drop Post-First Quarter ...
ISS Has Chosen Not to Hold the Board Accountable for Its Underperformance in Recent Years, Heplisav’s Waning Market Share Growth and Poor Corporate Governance “We firmly believe ISS reached the wrong ...
GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax ...
EMERYVILLE, Calif., Feb. 19, 2025 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX) (“Dynavax” or the “Company”), a commercial-stage biopharmaceutical company developing and ...
NEW YORK, Feb 19(Reuters) - Life sciences investment firm Deep Track Capital is launching a board fight at Dynavax Technologies (DVAX.O), opens new tab, pressing for new directors to prioritize the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results